5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
The Australia Veterinary Healthcare Market is Segmented on the basis of Product (Therapeutics and Diagnostics) and Animal Type (Dogs and Cats, Horses, Ruminants, Swine, Poultry, and Other Animals)
Australia veterinary healthcare market is projected to lead by advancements in health technology, leading to innovations in animal healthcare and increasing animal adoption in Australia coupled with animal health spending. According to the Animal Medicine Australia 2019 Survey, the Australian households own an estimated total of 5.1 million dogs, 3.8 million cats, 11.3 million fish, 5.6 million birds, 614,000 small mammals, 364,000 reptiles and 1.8 million other pets.
Additionally, growing meat consumption, especially of chicken and pork, the risk of emerging new strains of influenza viruses, and an increase in pet health awareness among the owners are also propelling the growth of the market. Also, there is a shift in the trend toward the use of counterfeit medicines for animal health, which is usually cheap, of low quality, and are produced without adequate testing. These act as restraints for the market's growth.
Furthermore increasing government initiatives on animal health and new product launches projected to propel the growth of the market over the forecast period. For instance, The National animal health surveillance and diagnostics business plan 2016–2019 was established by the Australian government and livestock industries to guide the delivery of surveillance activities, in accordance with nationally agreed objectives and priorities.
In October 2019, Australian researchers at the University of Sydney identified a newly discovered feline virus called as domestic cat hepadnavirus (DCH) might be the cause of liver cancer in cats, and that this link could lead to the development of new anti-cancer therapies. The increase in R&D in animal healthcare coupled with the availability of wide range of solutions are projected to boost the australia veterianry healthcare market over the forecast period.
As per the scope of this report, the Australian veterinary healthcare market is growing, and it comprises therapeutic and diagnostic products and solutions for companion and farm animals. Companion animals can be tamed or adopted for companionship or as house/office guards, and farm animals are raised for meat and milk-related products. Companion animals include canines, felines, and equines. Farm animals include bovine, poultry, and porcine.
|By Animal Type|
|Dogs and Cats|
Report scope can be customized per your requirements. Click here.
To understand key trends, Download Sample Report
The Australian veterinary healthcare market is majorly dominated by a few players. However, there are a few companies that are currently penetrating the market and are expected to hold substantials shares in the market. The major players are Zoetis Animal Healthcare, Merck Animal Health, Bayer Animal Health, Ceva Animal Health Inc., Virbac Corporation, Boehringer Ingelheim, Elanco Animal Health, and Apiam Animal Health, among others.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increase in Pet Adoption
4.2.2 Advanced Technology in Animal Healthcare
4.2.3 Rise in the number of Initiatives by Governments and Animal Welfare Associations
4.3 Market Restraints
4.3.1 Use of Counterfeit Medicines
4.3.2 Increasing Costs of Animal Testing and Veterinary Care
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Product
5.1.1 By Therapeutics
22.214.171.124 Medical Feed Additives
126.96.36.199 Other Therapeutics
5.1.2 By Diagnostics
188.8.131.52 Immunodiagnostic Tests
184.108.40.206 Molecular Diagnostics
220.127.116.11 Diagnostic Imaging
18.104.22.168 Clinical Chemistry
22.214.171.124 Other Diagnostics
5.2 By Animal Type
5.2.1 Dogs and Cats
5.2.6 Other Animals
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Bayer AG
6.1.2 Boehringer Ingelheim
6.1.4 Merck Co. Inc.
6.1.5 Vetoquinol SA
6.1.7 Zoetis Inc.
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments